Advertisement
Original article| Volume 7, ISSUE 4, P436-441, August 1993

Download started.

Ok

Transesophageal atrial pacing for intraoperative sinus bradycardia or AV junctional rhythm: feasibility as prophylaxis in 200 anesthetized adults and hemodynamic effects of treatment

  • John L. Atlee III
    Correspondence
    Address reprint requests to John L. Atlee, III, MD, Department of Anesthesiology (MCMC), Medical College of Wisconsin, 8700 West Wisconsin Ave, Milwaukee, WI 53226.
    Affiliations
    From the Departments of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, and Internal Medicine, Division of Cardiology, Ludvika Hospital, Ludvika, Sweden
    Search for articles by this author
  • Christine Z. Pattison
    Affiliations
    From the Departments of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, and Internal Medicine, Division of Cardiology, Ludvika Hospital, Ludvika, Sweden
    Search for articles by this author
  • Edwin L. Mathews
    Affiliations
    From the Departments of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, and Internal Medicine, Division of Cardiology, Ludvika Hospital, Ludvika, Sweden
    Search for articles by this author
  • Anders G. Hedma
    Affiliations
    From the Departments of Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, and Internal Medicine, Division of Cardiology, Ludvika Hospital, Ludvika, Sweden
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Sinus bradycardia (SB) or atrioventricular junctional rhythm (AVJR) may produce circulatory insufficiency in anesthetized surgical patients, especially those with cardiovascular disease. Chronotropic drugs have been the preferred initial treatment, except when epicardial pacing is available. Alternative methods include transvenous or transcutaneous pacing. Drugs may be ineffective or have undesirable effects. Transvenous pacing is time consuming and risky, and transcutaneous pacing is not universally applicable or effective. Transesophageal atrial pacing (TAP) lacks these disadvantages, but unavailability of equipment and unfamiliarity with the method has discouraged widespread use. Feasibility of TAP as prophylaxis for intraoperative SB or AVJR was tested with approved or investigational devices in 200 anesthetized surgical patients, not necessarily with cardiovascular disease or having cardiac surgery. Of these, 84 later had incidental SB ≤60 beats/min, and 23 of these 84 had SB ≤50 beats/min. Thirteen patients had AVJR (72 ± 4 beats/ min; mean ± SEM). TAP at 80 beats/min for SB, or at a rate sufficient to overdrive AVJR, was effective initial treatment in all patients. Respective average increases in systolic, diastolic, and mean arterial pressures for patients with SB ≤60 beats/ min were 14,12, and 14 mmHg (P < .001); for SB ≤50 beats/min 22,17, and 19 mmHg (P < .001); and for AVJR 23 (P < .01), 9 (NS), and 15 mmHg (P < .05), respectively. For patients with cardiac output measurements the average increase for SB ≤60 beats/min was 1.4 L/min (N = 13, P < .01); for SB ≤50 beats/min 1.8 L/min (N = 7, P < .05); and for AVJR was 2.6 L/mmin (N = 2). There were no apparent complications of TAP as prophylaxis or treatment for SB or AVJR. TAP has been shown to be a safe, simple, rapid, and effective method for prophylaxis and initial treatment of intraoperative SB or AVJR. Potential advantages of TAP over drugs are discussed.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Atlee J.L.
        Perioperative Cardiac Dysrhythmias.
        in: ed 2. Year Book Medical, Chicago, IL1990: 57-118
        • Atlee J.L.
        Perioperative Cardiac Dysrhythmias. ed 2. Year Book Medical, Chicago, IL1990: 187-273
        • Mitchell J.H.
        • Gilmore J.P.
        • Sarnoff S.J.
        The transport function of the atrium. Factors influencing the relation between mean left atrial pressure and left ventricular end-diastolic pressure.
        Am J Cardio. 1962; 19: 237-247
        • Stauffer J.C.
        • Gaasch W.H.
        Recognition and treatment of left ventricular diastolic dysfunction.
        Prog Cardiovasc Dis. 1990; 32: 319-332
        • Dean J.W.
        • Poole-Wilson P.A.
        Therapeutic implications of diastolic dysfunction in heart failure.
        Postgrad Med J. 1990; 66: 932-937
        • Bonow R.O.
        Regional left ventricular nonuniformity. Effects on left ventricular diastolic function in ischemic heart disease, hypertrophic myopathy, and the normal heart.
        Circulation. 1990; 81: 54-55
        • Packer M.
        Abnormalities of diastolic function as a potential cause of exercise intolerance in chronic heart failure.
        Circulation. 1990; 81: 78-86
        • Baig M.W.
        • Perrins E.J.
        The hemodynamics of cardiac pacing: Clinical and physiological aspects.
        Prog Cardiovasc Dis. 1991; 33: 283-298
        • Bocka J.M.
        External transcutaneous pacemakers.
        Ann Emerg Med. 1989; 18: 1280-1296
        • Backofen J.E.
        • Schauble J.F.
        • Rogers M.C.
        Transesophageal pacing for bradycardia.
        Anesthesiology. 1984; 61: 777-779
        • Buchanan D.
        • Clemments F.
        • Reves J.G.
        • et al.
        Atrial esophageal pacing in patients undergoing coronary artery bypass grafting: Effect of previous cardiac operations and body surface area.
        Anesthesiology. 1988; 69: 595-598
        • Pattison C.Z.
        • Atlee III, J.L.
        • Krebs L.H.
        • et al.
        Transesophageal indirect atrial pacing for drug-resistant sinus bradycardia.
        Anesthesiology. 1991; 74: 1141-1144
        • Benson Jr, D.W.
        Transesophageal electrocardiography and cardiac pacing: State of the art.
        Circulation. 1987; 75: 86-90
        • Lambertz H.
        • Kreis A.
        • Trumper H.
        • Hanrath P.
        Simultaneous transesophageal atrial pacing and transesophageal two-dimensional echocardiography: A new method of stress echocardiography.
        J Am Coll Cardiol. 1990; 16: 1143-1153
        • Pattison C.Z.
        • Atlee III, J.L.
        • Mathews E.L.
        • et al.
        Atrial pacing thresholds measured in anesthetized patients with the use of an esophageal stethoscope modified for pacing.
        Anesthesiology. 1991; 74: 854-859
        • Atlee J.L.
        • Pattison C.Z.
        • Mathews E.L.
        • et al.
        Evaluation of transesophageal atrial pacing stethoscope in adult surgical patients under general anesthesia.
        PACE. 1992; 15: 1515-1525
        • Benson Jr, D.W.
        • Sanford M.
        • Dunnigan A.
        • Benditt D.G.
        Transesophageal atrial pacing threshold: Role of interelectrode spacing, pulse width, and catheter insertion depth.
        Am J Cardiol. 1984; 53: 63-67
        • Bosnjak Z.J.
        • Kampine J.P.
        Effects of halothane, enflurane, and isoflurane on the SA node.
        Anesthesiology. 1983; 58: 314-321
        • Atlee J.L.
        • Yeager T.S.
        Electrophysiologic assessment of the effects of enflurane, halothane, and isoflurane on properties affecting supraventricular re-entry in chronically instrumented dogs.
        Anesthesiology. 1989; 71: 941-952
        • Kelly J.S.
        • Royster R.L.
        Noninvasive transcutaneous cardiac pacing.
        Anesth Analg. 1989; 69: 229-238
        • Gallagher J.J.
        • Smith W.M.
        • Kerr C.R.
        • et al.
        Esophageal pacing: A diagnostic and therapeutic tool.
        Circulation. 1982; 65: 336-341